Total raised
—
Last: Undisclosed
Stage
Acquired
Founded
2006
Headcount
7
HQ
Haifa
Sector
Health Tech & Life Sciences
About
G&G Biotechnology is developing a complete product line of lightweight breast implants for augmentation and reconstruction. Based on its patented B-Lite technology, the company's implants have been designed and rigorously tested for quality and safety. B-Lite enables users to choose larger-volume implants while reducing the risks associated with the increased weight. In 2018, G&G Biotechnology merged with POLYTECH Health & Aesthetics and is now a subsidiary of POLYTECH.
Funding history · 1 round · — total
Date unknown
Undisclosed
Undisclosed
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is the primary product of G&G Biotechnology?
- G&G Biotechnology develops a complete product line of lightweight breast implants for augmentation and reconstruction, based on its patented B-Lite technology.
- When was G&G Biotechnology founded?
- G&G Biotechnology was founded in April 2006.
- What was the status of G&G Biotechnology as of July 2018?
- In July 2018, G&G Biotechnology was acquired by POLYTECH Health & Aesthetics and became an inactive subsidiary.
- Which company acquired G&G Biotechnology?
- G&G Biotechnology was acquired by POLYTECH Health & Aesthetics in July 2018.
- Where is G&G Biotechnology headquartered?
- G&G Biotechnology is headquartered in Haifa, Israel.
- How many employees did G&G Biotechnology have?
- G&G Biotechnology had 7 employees.
- Who are the founders of G&G Biotechnology?
- The founders of G&G Biotechnology are Dael Govreen-Segal and Jacky Govrin-Yehudain.
- What is the key benefit of G&G Biotechnology's B-Lite technology?
- B-Lite technology enables users to choose larger-volume implants while reducing the risks associated with increased weight.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
Materials & SubstancesImplants
Target customers
Healthcare & Life SciencesLife SciencesBiotechnologyHealthcareProvidersConsumersDemographics & FamilyWomen
Business model
B2B2C
Highlights
1 Patents
Tags
women-healthsurgeonsmedical-productsmedical-technologiesbiotechnologypolymerswomen